how long have people been using glp 1 GLP-1s and the Unintended Consequences of the $100 Billion Market GLP-1 Genetics: How Genes Affect

You can find premiums by going to the last page of the plans official FEHB brochure

The ADA 2026 Standards of Care now recommend GLP-1 receptor agonists with demonstrated cardiovascular benefit for patients with type 2 diabetes and established ASCVD, multiple cardiovascular risk factors, or chronic kidney disease, and note that combination with SGLT2 inhibitors may provide additive benefit

A history of pancreatitis also raises concern

In June, the European Medicines Agencys Pharmacovigilance Risk Assessment Committee (PRAC) concluded that NAION is a very rare side effect of semaglutide-based medications, recommending that vision risks be added to product warnings

GLP-1 Medicaid Coverage by State Despite some states offering limited coverage of GLP-1s to treat weight loss as far back as a decade ago, most states that currently provide coverage through taxpayer-funded Medicaid programs or state employee health plans have only opted to do so within the past five years

Krner, M., Stckli, M., Waser, B